The results concerning the role of cPLA2 in EGF-induced PAF production, along with the convergence of signaling molecules on cPLA2, suggest that cPLA2 may be a potential therapeutic target in ovarian cancer. The gene discussed is EGF; the disease is ovarian carcinoma.